Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Epidemiology of Hepatitis B Virus infection: Prevalence, vaccine coverage and its barriers in Katagum Local Government Area, Bauchi State Nigeria

View through CrossRef
Hepatitis B Virus (HBV) remains a major global health challenge, particularly in developing countries where vaccination coverage is low.  This study aimed to assess the prevalence of HBV infection, knowledge, attitudes, and vaccine uptake among patients in Katagum Local  Government Area Bauchi State, Nigeria. A total of 385 patients were recruited for the study. Blood samples were collected and tested for  HBV surface antigen (HbsAg) using a rapid detection kit. Demographic data, vaccination status, and knowledge of HBV were obtained  through structured questionnaires. Data were analyzed using descriptive and inferential statistics. The overall prevalence of HBV was  3.9%, with a higher rate in males (2.6%) compared to females (1.3%). Adults aged 25–64 years had the highest prevalence (2.6%), while no  cases were recorded among individuals above 65 years. Rural residents had a higher prevalence (2.34%) than urban residents (1.56%). Vaccination coverage was 43.38%, with higher uptake among urban residents (23.38%) and males (35.06%). Marital status (p = 0.049) and  place of residence (p = 0.000) were significantly associated with vaccine uptake. Knowledge of HBV was significantly linked to vaccination  status (p = 0.031), as were attitudes toward the disease and its prevention (p < 0.001). The main barriers to vaccination were lack of  awareness (42.20%), fear of side effects (22.94%), and negative attitudes toward vaccination (20.64%). The study highlighted a moderate  HBV prevalence and suboptimal vaccination coverage in Katagum LGA, Bauchi State. There is a need for intensified awareness  campaigns, improved vaccine accessibility, and targeted interventions to increase HBV vaccination rates, particularly in rural areas and  among vulnerable groups. 
Title: Epidemiology of Hepatitis B Virus infection: Prevalence, vaccine coverage and its barriers in Katagum Local Government Area, Bauchi State Nigeria
Description:
Hepatitis B Virus (HBV) remains a major global health challenge, particularly in developing countries where vaccination coverage is low.
  This study aimed to assess the prevalence of HBV infection, knowledge, attitudes, and vaccine uptake among patients in Katagum Local  Government Area Bauchi State, Nigeria.
A total of 385 patients were recruited for the study.
Blood samples were collected and tested for  HBV surface antigen (HbsAg) using a rapid detection kit.
Demographic data, vaccination status, and knowledge of HBV were obtained  through structured questionnaires.
Data were analyzed using descriptive and inferential statistics.
The overall prevalence of HBV was  3.
9%, with a higher rate in males (2.
6%) compared to females (1.
3%).
Adults aged 25–64 years had the highest prevalence (2.
6%), while no  cases were recorded among individuals above 65 years.
Rural residents had a higher prevalence (2.
34%) than urban residents (1.
56%).
Vaccination coverage was 43.
38%, with higher uptake among urban residents (23.
38%) and males (35.
06%).
Marital status (p = 0.
049) and  place of residence (p = 0.
000) were significantly associated with vaccine uptake.
Knowledge of HBV was significantly linked to vaccination  status (p = 0.
031), as were attitudes toward the disease and its prevention (p < 0.
001).
The main barriers to vaccination were lack of  awareness (42.
20%), fear of side effects (22.
94%), and negative attitudes toward vaccination (20.
64%).
The study highlighted a moderate  HBV prevalence and suboptimal vaccination coverage in Katagum LGA, Bauchi State.
There is a need for intensified awareness  campaigns, improved vaccine accessibility, and targeted interventions to increase HBV vaccination rates, particularly in rural areas and  among vulnerable groups.
 .

Related Results

The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Burden of the Beast
Burden of the Beast
Introduction Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Seroprevalence and clinical outcome of hepatitis D infection in Qatar
Seroprevalence and clinical outcome of hepatitis D infection in Qatar
Background: Worldwide, 5–10% of people with chronic hepatitis B virus infection are co-infected with hepatitis D virus. In Qatar, there are no data on hepatitis D virus infection a...

Back to Top